{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:59:33Z","timestamp":1790207973408,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Approximately 70% of patients with advanced breast cancer develop bone metastases, accompanied by complications, such as bone pain, fracture, and hypercalcemia. However, our understanding of the molecular mechanisms that govern this process remains fragmentary. Osterix (Osx) is a zinc finger-containing transcription factor essential for osteoblast differentiation and bone formation. Here, we identified the functional roles of Osx in facilitating breast cancer invasion and bone metastasis. Osx upregulation was associated with lymph node metastasis and was negatively prognostic for overall survival. Knockdown of Osx inhibited invasion of breast cancer and osteolytic metastasis by downregulating MMP9, MMP13, VEGF, IL-8, and PTHrP, which are involved in invasion, angiogenesis, and osteolysis; overexpression of Osx had the opposite effect. Moreover, MMP9 was a direct target of Osx and mediated the Osx-driven invasion of breast cancer cells. Together, our data showed that Osx facilitates bone metastasis of breast cancer by upregulating the expression of a cohort of genes that contribute to steps in the metastatic cascade. These findings suggest that Osx is an attractive target for the control of bone metastasis of breast cancers.<\/jats:p>","DOI":"10.1038\/s41419-018-1269-3","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T09:16:46Z","timestamp":1547111806000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Upregulated osterix promotes invasion and bone metastasis and predicts for a poor prognosis in breast cancer"],"prefix":"10.1038","volume":"10","author":[{"given":"Bing","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuci","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"key":"1269_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10555-015-9551-7","volume":"34","author":"A McGuire","year":"2015","unstructured":"McGuire, A., Brown, J. A. & Kerin, M. J. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring. Cancer Metastas-. Rev. 34, 145\u2013155 (2015).","journal-title":"Cancer Metastas-. Rev."},{"key":"1269_CR2","doi-asserted-by":"publisher","first-page":"E1669","DOI":"10.3390\/ijms17101669","volume":"17","author":"DM Gilkes","year":"2016","unstructured":"Gilkes, D. M. Implications of hypoxia in breast cancer metastasis to bone. Int. J. Mol. Sci. 17, E1669 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"1269_CR3","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/bjc.1998.52","volume":"77","author":"RE Coleman","year":"1998","unstructured":"Coleman, R. E., Smith, P. & Rubens, R. D. Clinical course and prognostic factors following bone recurrence from breast cancer. Br. J. Cancer 77, 336\u2013340 (1998).","journal-title":"Br. J. Cancer"},{"key":"1269_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-179","volume":"6","author":"K Manders","year":"2006","unstructured":"Manders, K. et al. Clinical management of women with metastatic breast cancer: a descriptive study according to age group. BMC Cancer 6, 179 (2006).","journal-title":"BMC Cancer"},{"key":"1269_CR5","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00520-015-2908-1","volume":"24","author":"R von Moos","year":"2016","unstructured":"von Moos, R. et al. Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases. Support Care Cancer 24, 1327\u20131337 (2016).","journal-title":"Support Care Cancer"},{"key":"1269_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.biocel.2018.01.003","volume":"96","author":"N Brook","year":"2018","unstructured":"Brook, N., Brook, E., Dharmarajan, A., Dass, C. R. & Chan, A. Breast cancer bone metastases: pathogenesis and therapeutic targets. Int. J. Biochem. Cell. Biol. 96, 63\u201378 (2018).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"1269_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/path.4871","volume":"241","author":"K Jin","year":"2017","unstructured":"Jin, K., Li, T., van Dam, H., Zhou, F. & Zhang, L. Molecular insights into tumour metastasis: tracing the dominant events. J. Pathol. 241, 567\u2013577 (2017).","journal-title":"J. Pathol."},{"key":"1269_CR8","first-page":"311","volume":"9","author":"OJ Scully","year":"2012","unstructured":"Scully, O. J., Bay, B. H., Yip, G. & Yu, Y. Breast cancer metastasis. Cancer Genom. Proteom. 9, 311\u2013320 (2012).","journal-title":"Cancer Genom. Proteom."},{"key":"1269_CR9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ccr.2013.09.007","volume":"24","author":"S Vanharanta","year":"2013","unstructured":"Vanharanta, S. & Massagu\u00e9, J. Origins of metastatic traits. Cancer Cell 24, 410\u2013421 (2013).","journal-title":"Cancer Cell"},{"key":"1269_CR10","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/nm.3391","volume":"19","author":"L Wan","year":"2013","unstructured":"Wan, L., Pantel, K. & Kang, Y. Tumor metastasis: moving new biological insights into the clinic. Nat. Med. 19, 1450\u20131464 (2013).","journal-title":"Nat. Med."},{"key":"1269_CR11","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang, Y. et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537\u2013549 (2003).","journal-title":"Cancer Cell"},{"key":"1269_CR12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature03799","volume":"436","author":"AJ Minn","year":"2005","unstructured":"Minn, A. J. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518\u2013524 (2005).","journal-title":"Nature"},{"key":"1269_CR13","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nature08021","volume":"459","author":"PD Bos","year":"2009","unstructured":"Bos, P. D. et al. Genes that mediate breast cancer metastasis to the brain. Nature 459, 1005\u20131009 (2009).","journal-title":"Nature"},{"key":"1269_CR14","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/onc.2010.518","volume":"30","author":"S Tabari\u00e8s","year":"2011","unstructured":"Tabari\u00e8s, S. et al. Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes. Oncogene 30, 1318\u20131328 (2011).","journal-title":"Oncogene"},{"key":"1269_CR15","first-page":"5571","volume":"62","author":"MS Bendre","year":"2002","unstructured":"Bendre, M. S. et al. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Res. 62, 5571\u20135579 (2002).","journal-title":"Cancer Res."},{"key":"1269_CR16","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ccr.2011.11.002","volume":"20","author":"X Lu","year":"2011","unstructured":"Lu, X. et al. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging \u03b14\u03b21-positive osteoclast progenitors. Cancer Cell 20, 701\u2013714 (2011).","journal-title":"Cancer Cell"},{"key":"1269_CR17","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1172\/JCI118947","volume":"98","author":"TA Guise","year":"1996","unstructured":"Guise, T. A. et al. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J. Clin. Invest. 98, 1544\u20131549 (1996).","journal-title":"J. Clin. Invest."},{"key":"1269_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0092-8674(01)00622-5","volume":"108","author":"K Nakashima","year":"2002","unstructured":"Nakashima, K. et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17\u201329 (2002).","journal-title":"Cell"},{"key":"1269_CR19","doi-asserted-by":"publisher","first-page":"12919","DOI":"10.1073\/pnas.0912855107","volume":"107","author":"X Zhou","year":"2010","unstructured":"Zhou, X. et al. Multiple functions of Osterix are required for bone growth and homeostasis in postnatal mice. Proc. Natl Acad. Sci. USA 107, 12919\u201312924 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1269_CR20","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/jbm.a.31356","volume":"83","author":"H Fu","year":"2007","unstructured":"Fu, H., Doll, B., McNelis, T. & Hollinger, J. O. Osteoblast differentiation in vitro and in vivo promoted by Osterix. J. Biomed. Mater. Res. A 83, 770\u2013778 (2007).","journal-title":"J. Biomed. Mater. Res. A"},{"key":"1269_CR21","doi-asserted-by":"publisher","first-page":"6936","DOI":"10.1073\/pnas.0710831105","volume":"105","author":"C Zhang","year":"2008","unstructured":"Zhang, C. et al. Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix. Proc. Natl Acad. Sci. USA 105, 6936\u20136941 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1269_CR22","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1074\/jbc.M111.288472","volume":"287","author":"W Tang","year":"2012","unstructured":"Tang, W. et al. Transcriptional regulation of Vascular Endothelial Growth Factor (VEGF) by osteoblast-specific transcription factor Osterix (Osx) in osteoblasts. J. Biol. Chem. 287, 1671\u20131678 (2012).","journal-title":"J. Biol. Chem."},{"key":"1269_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.bbrc.2012.06.104","volume":"424","author":"D Chen","year":"2012","unstructured":"Chen, D., Tian, W., Li, Y., Tang, W. & Zhang, C. Osteoblast-specific transcription factor Osterix (Osx) and HIF-1\u03b1 cooperatively regulate gene expression of vascular endothelial growth factor (VEGF). Biochem. Biophys. Res. Commun. 424, 176\u2013181 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1269_CR24","doi-asserted-by":"publisher","first-page":"e50525","DOI":"10.1371\/journal.pone.0050525","volume":"7","author":"C Zhang","year":"2012","unstructured":"Zhang, C., Tang, W. & Li, Y. Matrix metalloproteinase 13 (MMP13) is a direct target of osteoblast-specific transcription factor osterix (Osx) in osteoblasts. PLoS One 7, e50525 (2012).","journal-title":"PLoS One"},{"key":"1269_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3047","volume":"13","author":"E Pivetta","year":"2011","unstructured":"Pivetta, E. et al. MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases. Breast Cancer Res. 13, R105 (2011).","journal-title":"Breast Cancer Res."},{"key":"1269_CR26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.bone.2011.07.027","volume":"49","author":"C Niger","year":"2011","unstructured":"Niger, C. et al. The transcriptional activity of osterix requires the recruitment of Sp1 to the osteocalcin proximal promoter. Bone 49, 683\u2013692 (2011).","journal-title":"Bone"},{"key":"1269_CR27","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1158\/0008-5472.CAN-04-2128","volume":"65","author":"Y Cao","year":"2005","unstructured":"Cao, Y. et al. Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma. Cancer Res. 65, 1124\u20131128 (2005).","journal-title":"Cancer Res."},{"key":"1269_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1006\/scbi.1996.0020","volume":"7","author":"WG Stetler-Stevenson","year":"1996","unstructured":"Stetler-Stevenson, W. G., Hewitt, R. & Corcoran, M. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin. Cancer Biol. 7, 147\u2013154 (1996).","journal-title":"Semin. Cancer Biol."},{"key":"1269_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000468614","volume":"49","author":"HC Crawford","year":"1996","unstructured":"Crawford, H. C. & Matrisian, L. M. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 49, 20\u201337 (1996).","journal-title":"Enzyme Protein"},{"key":"1269_CR30","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1074\/jbc.271.3.1544","volume":"271","author":"V Kn\u00e4uper","year":"1996","unstructured":"Kn\u00e4uper, V., L\u00f3pez-Otin, C., Smith, B., Knight, G. & Murphy, G. Biochemical characterization of human collagenase-3. J. Biol. Chem. 271, 1544\u20131550 (1996).","journal-title":"J. Biol. Chem."},{"key":"1269_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/10409230290771546","volume":"37","author":"PE Van den Steen","year":"2002","unstructured":"Van den Steen, P. E. et al. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37, 375\u2013536 (2002).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"1269_CR32","doi-asserted-by":"publisher","first-page":"38577","DOI":"10.1074\/jbc.M403738200","volume":"279","author":"S Nozell","year":"2004","unstructured":"Nozell, S., Ma, Z., Wilson, C., Shah, R. & Benveniste, E. N. Class II major histocompatibility complex transactivator (CIITA) inhibits matrix metalloproteinase-9 gene expression. J. Biol. Chem. 279, 38577\u201338589 (2004).","journal-title":"J. Biol. Chem."},{"key":"1269_CR33","first-page":"225","volume":"20","author":"M Kotepui","year":"2016","unstructured":"Kotepui, M. et al. Differential expression of matrix metalloproteinase-13 in association with invasion of breast cancer. Contemp. Oncol. 20, 225\u2013228 (2016).","journal-title":"Contemp. Oncol."},{"key":"1269_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-83","volume":"8","author":"B Zhang","year":"2008","unstructured":"Zhang, B. et al. Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer. BMC Cancer 8, 83 (2008).","journal-title":"BMC Cancer"},{"key":"1269_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2325\/jbcs.968","volume":"14","author":"H Bando","year":"2007","unstructured":"Bando, H. Vascular endothelial growth factor and bevacizumab in breast cancer. Breast Cancer 14, 163\u2013173 (2007).","journal-title":"Breast Cancer"},{"key":"1269_CR36","unstructured":"Guise, T. A., Chirgwin, J. M. Biology of bone metastases. In: Diseases of the Breast, 3rd edn, Vol. 1285 (eds. Harris, J. R., Lippman, M. E., Morrow, M. & Osborne, C. K.) 96 (Lippincott Williams & Wilkins, Philadelphia, PA, 2004)."},{"issue":"Suppl. 2","key":"1269_CR37","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.3816\/CBC.2005.s.004","volume":"5","author":"TA Guise","year":"2005","unstructured":"Guise, T. A. et al. Molecular mechanisms of breast cancer metastases to bone. Clin. Breast Cancer 5(Suppl. 2), S46\u2013S53 (2005).","journal-title":"Clin. Breast Cancer"},{"key":"1269_CR38","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1158\/0008-5472.CAN-09-3251","volume":"70","author":"KC Nannuru","year":"2010","unstructured":"Nannuru, K. C. et al. Matrix metalloproteinase (MMP) 13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-\u03b2 signaling at the tumor-bone interface. Cancer Res. 70, 3494\u20133504 (2010).","journal-title":"Cancer Res."},{"key":"1269_CR39","doi-asserted-by":"publisher","first-page":"e56451","DOI":"10.1371\/journal.pone.0056451","volume":"8","author":"Y Peng","year":"2013","unstructured":"Peng, Y. et al. Characterization of osterix protein stability and physiological role in osteoblast differentiation. PLoS One 8, e56451 (2013).","journal-title":"PLoS One"},{"key":"1269_CR40","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/jcb.22635","volume":"110","author":"N Yang","year":"2010","unstructured":"Yang, N. et al. Poly (ADP-ribose) polymerase-1 binds to BCL2 major breakpoint region and regulates BCL2 expression. J. Cell. Biochem. 110, 1208\u20131218 (2010).","journal-title":"J. Cell. Biochem."},{"key":"1269_CR41","doi-asserted-by":"publisher","first-page":"14205","DOI":"10.1073\/pnas.2234372100","volume":"100","author":"SJ Bakewell","year":"2003","unstructured":"Bakewell, S. J. et al. Platelet and osteoclast beta3 integrins are critical for bone metastasis. Proc. Natl Acad. Sci. USA 100, 14205\u201314210 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"}],"updated-by":[{"DOI":"10.1038\/s41419-022-04545-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000}}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1269-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1269-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1269-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T16:28:05Z","timestamp":1671208085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1269-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1]]}},"alternative-id":["1269"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-1269-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]},"assertion":[{"value":"5 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41419-022-04545-x","URL":"https:\/\/doi.org\/10.1038\/s41419-022-04545-x","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"28"}}